1267.0000 -12.90 (-1.01%)
NSE Sep 02, 2025 12:14 PM
Volume: 758.1K
 

1267.00
-1.01%
Phillip Capital
Key highlights: Sales were below expectations on account of weakEurope, PSAI andIndia sales.TheUSsalesatUS$286mn(+10%yoy)wasinlineourestimatedofUS$290mn.There was 300bps negative surprise in EBITDA margin at 21.6% due to lower gross margin and...
Dr. Reddy's Laboratories Ltd. is trading above its 200 day SMA of 1237.6
More from Dr. Reddy's Laboratories Ltd.
Recommended